Using the Open Targets Platform, we found that several cancers, neurological diseases, pulmonary diseases, cardiovascular diseases, and rheumatoid arthritis, among others, are critically associated with CHI3L1 (Fig. 1). This evidence concerns the gene CHI3L1 and cancer.